文献速递主动脉疾病

EVAR术后五年生存的预测因素:单中心队列研究10年经验

Predictors of Five-Year Survival after EVAR: 10-Year Experience of Single-Center Cohort Study.
PubMed 文献 · Ann Vasc Surg · 2023-04-15

本单中心回顾性队列研究纳入2007至2017年在德黑兰心脏中心成功接受EVAR的154例完整孤立性腹主动脉瘤患者,中位随访65.5个月,5年生存率为75%(3.9%)。年龄(HR=1.06,P=0.002)和贫血(HR=1.91,P=0.029)是5年生存的独立预测因素,而血脂异常(HR=0.573,P=0.078)和ICU/CCU住院时间长(HR=1.08,P=0.070)为临界预测因素但未达统计学显著。

要点

  • 5年生存率为75%(3.9%),中位随访65.5个月。
  • 年龄(HR=1.06,P=0.002)和贫血(HR=1.91,P=0.029)是独立预测因素。
  • 血脂异常(HR=0.573,P=0.078)和ICU/CCU住院时间长(HR=1.08,P=0.070)为临界预测因素,未达统计学显著。

核心结论

  • 本研究显示本中心EVAR术后患者5年生存率可接受。
  • 年龄和贫血这2个可干预的预测因素可能延长患者生存率,需后续评估。

研究设计与样本

  • 单中心回顾性队列研究,纳入2007至2017年在德黑兰心脏中心因完整孤立性腹主动脉瘤接受EVAR的患者。
  • 共纳入154例成功接受EVAR的患者,平均年龄70.7(±8.0)岁,男性占96.1%。
  • 采用Kaplan-Meier法估算5年生存率及其预测因素,中位随访65.5个月。

主要发现

  • 最常见危险因素为冠心病(70.1%)、高血压(68.2%)、吸烟(64.9%)和血脂异常(39.6%)。
  • 术中无死亡,随访期间腹主动脉瘤平均缩小9.07 mm(95%CI 6.9-11.2)。
  • 随访期间12例出现并发症,49例死亡,7例未完成随访。
  • 5年生存率为75%(3.9%)。
  • 年龄(HR=1.06,P=0.002)和贫血(HR=1.91,P=0.029)是5年生存的独立预测因素;血脂异常(HR=0.573,P=0.078)和ICU/CCU住院时间长(HR=1.08,P=0.070)为临界预测因素但未达统计学显著。

关键数值与推荐

  • 年龄:HR=1.06(P=0.002),为5年生存独立预测因素。
  • 贫血:HR=1.91(P=0.029),为5年生存独立预测因素。
  • 血脂异常:HR=0.573(P=0.078),未达统计学显著。
  • ICU/CCU住院时间长:HR=1.08(P=0.070),未达统计学显著。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endovascular abdominal aortic repair (EVAR) is the main therapeutic option for repairing abdominal aortic aneurysms (AAAs). We aimed to determine the long-term outcomes of patients who underwent EVAR at our center. METHODS: In this retrospective cohort study, patients who underwent EVAR for intact isolated AAA at Tehran Heart Center between 2007 and 2017 were included. Clinical outcomes and the frequency of mortality were analyzed for follow-up periods. We calculated the 5-year survival rate and its predictors for our patients using Kaplan-Meier estimation. RESULTS: We included the data of all patients (154 patients, mean age = 70.7 [± 8.0] years, 96.1% men) who successfully underwent EVAR at our center. The most common risk factors were coronary artery disease (70.1%), hypertension (68.2%), smoking (64.9%), and dyslipidemia (39.6%). There was no mortality during the procedure. The median follow-up was 65.5 months. An average decrease of 9.07 mm (95% confidence interval: 6.9-11.2) occurred in the size of the AAA. During follow-up, 12 patients developed some complications, 49 died, and 7 did not complete the follow-up. The 5-year survival rate was 75% (3.9%). The independent predictors for 5-year survival were age (hazard ratio [HR] = 1.06, P = 0.002) and anemia (HR = 1.91, P = 0.029). Despite not being statistically significant, dyslipidemia (HR = 0.573, P = 0.078) and long intensive care unit/cardiac care unit stays (HR = 1.08, P = 0.070) were borderline mortality predictors. CONCLUSIONS: This study depicted an acceptable survival rate for patients who underwent EVAR at our center. Age and anemia, 2 modifiable predictors of 5-year survival, can probably prolong the survival rate of patients, which requires evaluation later.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Torabi N, Shafiee A, Heidari A, et al. Predictors of Five-Year Survival after EVAR: 10-Year Experience of Single-Center Cohort Study. Ann Vasc Surg. 2023. PMID: 37068627. doi:10.1016/j.avsg.2023.03.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。